Ganciclovir and Valganciclovir Use Among Infants With Congenital Cytomegalovirus: Data From a Multicenter Electronic Health Record Dataset in the United States

被引:11
|
作者
Leung, Jessica [1 ]
Grosse, Scott D. [2 ]
Yockey, Bryan [1 ]
Lanzieri, Tatiana M. [1 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, 1600 Clifton Rd NE,MS H24-5, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA
关键词
antiviral; CMV; congenital cytomegalovirus; ganciclovir; valganciclovir; THERAPY;
D O I
10.1093/jpids/piac034
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Among 342 US infants with congenital cytomegalovirus treated with antivirals, 114 (33%) received ganciclovir (with or without valganciclovir) and 228 (67%) received valganciclovir only, for a median of 8 and 171 days, starting at a median of 15 and 45 days of life, respectively, with neutropenia diagnosed in 25% and 17%.
引用
收藏
页码:379 / 382
页数:4
相关论文
共 7 条
  • [1] Valganciclovir Use Among Commercially and Medicaid-insured Infants With Congenital CMV Infection in the United States, 2009-2015
    Leung, Jessica
    Dollard, Sheila C.
    Grosse, Scott D.
    Chung, Winnie
    ThuyQuynh Do
    Patel, Manisha
    Lanzieri, Tatiana M.
    CLINICAL THERAPEUTICS, 2018, 40 (03) : 430 - 439
  • [2] The Economic Burden of Congenital Cytomegalovirus Disease in the First Year of Life: A Retrospective Analysis of Health Insurance Claims Data in the United States
    Meyers, Juliana
    Sinha, Anushua
    Samant, Salome
    Candrilli, Sean
    CLINICAL THERAPEUTICS, 2019, 41 (06) : 1040 - 1056
  • [3] Laboratory testing and diagnostic coding for cytomegalovirus among privately insured infants in the United States: a retrospective study using administrative claims data
    Jessica Leung
    Michael J Cannon
    Scott D Grosse
    Stephanie R Bialek
    BMC Pediatrics, 13
  • [4] Laboratory testing and diagnostic coding for cytomegalovirus among privately insured infants in the United States: a retrospective study using administrative claims data
    Leung, Jessica
    Cannon, Michael J.
    Grosse, Scott D.
    Bialek, Stephanie R.
    BMC PEDIATRICS, 2013, 13
  • [5] No beneficial use of the wearable cardioverter defibrillator among patients suffering from inherited and congenital heart disease: data from a European multicenter registry
    Koepsel, Katharina
    Dreher, Tobias C.
    Blockhaus, Christian
    Gotzmann, Michael
    Klein, Norbert
    Kuntz, Thomas
    Shin, Dong-In
    Lapp, Hendrik
    Schiedat, Fabian
    Abumayyaleh, Mohammad
    Beiert, Thomas
    Weth, Christian
    Kovacs, Boldizsar
    Rosenkaimer, Stephanie
    Kowitz, Jacqueline
    Saguner, Ardan Muammer
    Erath, Julia W.
    Duru, Firat
    Muegge, Andreas
    Akin, Ibrahim
    Aweimer, Assem
    Hamdani, Nazha
    El-Battrawy, Ibrahim
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [6] Use of electronic health record data from diverse primary care practices to identify and characterize patients' prescribed common medications
    Cole, Allison M.
    Stephens, Kari A.
    West, Imara
    Keppel, Gina A.
    Thummel, Ken
    Baldwin, Laura-Mae
    HEALTH INFORMATICS JOURNAL, 2020, 26 (01) : 172 - 180
  • [7] Current Use of Aspirin and Antithrombotic Agents in the United States Among Outpatients With Atherothrombotic Disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)
    Cannon, Christopher P.
    Rhee, Karen E.
    Califf, Robert M.
    Boden, William E.
    Hirsch, Alan T.
    Alberts, Mark J.
    Cable, Greg
    Shao, Mingyuan
    Ohman, E. Magnus
    Steg, P. Gabriel
    Eagle, Kim A.
    Bhatt, Deepak L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (04) : 445 - 452